$INTC Intel Corp (INTC) Buy? Hold? Sell? Overall Average: 96%

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$INTC Overall Average: 96% Buy. $FNMA $UNG $VISN

Intel Corp (INTC) Buy - Hold - Sell - Overall Opinion

INTC Last Price: 25.78
Current Change: -0.01 (-0.04%)

Composite Indicators - Signal
TrendSpotter- Buy

Short Term Indicators
7 Day Average Directional Indicator- Buy
10 - 8 Day Moving Average Hilo Channel- Buy
20 Day Moving Average vs Price- Buy
20 - 50 Day MACD Oscillator- Buy
20 Day Bollinger Bands - Hold

Short Term Indicators Average: 80% Buy
20-Day Average Volume - 28,498,430


Medium Term Indicators
40 Day Commodity Channel Index- Buy
50 Day Moving Average vs Price- Buy
20 - 100 Day MACD Oscillator- Buy
50 Day Parabolic Time/Price- Buy

Medium Term Indicators Average: 100% Buy
50-Day Average Volume - 31,105,156

Long Term Indicators
60 Day Commodity Channel Index- Buy
100 Day Moving Average vs Price- Buy
50 - 100 Day MACD Oscillator- Buy

Long Term Indicators Average: 100% Buy
100-Day Average Volume - 31,280,305

Overall Average: 96% Buy

Price - Support - Pivot Point - Resistance
25.78 25.46 25.76 26.06


Last Updated: Sunday, January 5, 2014 12:00:33 PM

INTC Stock Message Board and Forum http://investorshangout.com/search?q=INTC&...mp;yt0=Go!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fair Play in Focus: SYNA, CSR, VCTR, EFSI Deals Scrutinized

Updated Category News Views 94

The Corporate Buzz: Deals Under the Microscope Riding the rollercoaster of mergers and acquisitions ain't new in the stock market realm. But when the stakes seem one-sided, alarms start ringing. Halper Sadeh LLC, a firm that cuts its teeth on this kind of corporate sleuthing, is all hands on deck probing a slew of big deals involving Synaptics (NASDAQ:SYNA), Centerspace...

Continue Reading
Cumberland Pharmaceuticals Eyes NDA for Ifetroban in DMD

Updated Category News Views 25

Rolling the Dice with Ifetroban There's a buzz in the air around Cumberland Pharmaceuticals as they gear up to tackle one of medicine's stubborn giants, Duchenne muscular dystrophy (DMD). They plan to file a New Drug Application (NDA) with the FDA for ifetroban, aiming to treat the cardiomyopathy plaguing many DMD sufferers. Folks who’ve watched Cumberland (NASDAQ:CPIX)...

Continue Reading
Huntington Bank Bolsters Westside Future Fund with $1M Boost

Updated Category News Views 163

Huntington's Commitment Goes Beyond Dollars In a world where corporations often toss out pretty phrases without the substance to back them up, Huntington Bank's $1 million shout-out to Atlanta's Westside Future Fund (WFF) speaks volumes. This ain't your run-of-the-mill PR move. It's a solid, tangible effort to help a community that's rich in history but screaming for...

Continue Reading
Rethinking Your Social Security Timing Strategy

Updated Category News Views 117

Janie Kelly Challenges Conventional Wisdom Janie Kelly, the brain behind Kelly Capital Partners, just dropped a truth bomb on when to start claiming Social Security benefits, wrapped in a HelloNation article that lays it all out sans fluff. Forget about hopping on the bandwagon and claiming at the earliest shot—this is a decision as personal as it gets. It's all about...

Continue Reading
ConsensusAI by IDMEXPRESS: A New Era for Course Reviews

Updated Category News Views 77

Revolutionizing Course Quality Reviews Well, look who decided to shake things up in the world of higher education! IDMEXPRESS has rolled out a tool called ConsensusAI, aimed squarely at transforming how colleges and universities handle course quality reviews. The announcement hit the streets on October 26, 2026, leaving education stakeholders both curious and intrigued....

Continue Reading
Electra's Ultra Short Aircraft Revolutionizes Air Travel

Updated Category News Views 138

From Tarmacs to Heliports: A New Era in Air Travel The aviation world doesn’t often see a sea change, but when a fixed-wing flyer touches down at a heliport, it grabs your attention. Electra’s recent leap into Manhattan’s Downtown Skyport highlights a promising shift in regional air mobility, doing away with the age-old reliance on long runways. It’s a shift that...

Continue Reading
Endava Class Action: Investor Concerns Unveiled

Updated Category News Views 88

What's Happened with Endava? Endava plc, trading under NYSE:DAVA, just got pummeled. A lawsuit is making waves, targeting investors who bought into Endava between September 2025 and 2026. What's the fuss about? Their stock tanked 25% on September 22, 2026, following an unsettling revelation: the company disclosed serious management and potential accounting problems. A...

Continue Reading
E-Filing: Why Ditching IRS Paper Forms Matters Now

Updated Category News Views 153

Tax Filing Today: The Old vs. The New Listen up, tax-filing warriors. Tackling that IRS Form 941 deadline isn’t just another play in the small business game—it’s crunch time. November 2, 2026, isn’t waiting around for excuses. Luckily, Halfpricesoft.com just chucked you a lifeline with their updated ezPaycheck platform. Swap that mountain of mangled paper forms...

Continue Reading
ASICS and University of Michigan Launch Innovation Lab

Updated Category News Views 154

Running Innovation Gets a Boost in Ann Arbor On a crisp fall day up in Ann Arbor, ASICS and the University of Michigan have decided it's high time to shake up the world of running product R&D. These two powerhouses just launched the ASICSx Michigan Sport Innovation Center (AMSI), an academic-industry research lab. It's like they're mixing college smarts with business...

Continue Reading
BETR Faces Shareholder Suit After Plummeting Stock

Updated Category News Views 29

Better Home & Finance Navigates Turbulent Waters Not every day the news comes up smelling of roses, and that's putting it lightly for Better Home & Finance, trading as NASDAQ: BETR. When you're talking about a splash that sends shockwaves, losing over 28% of your stock value on a single trading day is one whale of a splash indeed. The Numbers That Shook the Waters It's no...

Continue Reading

Top 5 Most Recently Viewed Articles

Dr. Chitra Rajagopal Joins American Oncology Network Team

Updated Category News Views 186

Welcoming Dr. Chitra Rajagopal to the Oncology Team American Oncology Network (AON), known for its rapid growth in community-based oncology practices, proudly announces the addition of Dr. Chitra Rajagopal, an esteemed medical oncologist. Her presence enhances the physician care team at The Center for Cancer and Blood Disorders, where she will be treating patients in the...

Continue Reading
Positive Earnings Outlook for Rapid Micro Biosystems Ahead

Updated Category News Views 137

Earnings Forecast for Rapid Micro Biosystems Rapid Micro Biosystems (NASDAQ: RPID) is poised to reveal its quarterly earnings soon. Investors are eager to see if the company can meet or exceed analyst expectations, particularly as they await the announcement regarding an estimated earnings per share (EPS) of $-0.26. This figure serves as a benchmark, providing insight...

Continue Reading
AppLovin's Options Activity: Insights and Future Implications

Updated Category News Views 162

Understanding Recent Options Activity of AppLovin In the world of stocks and investments, intriguing signals often emerge, especially when deep-pocketed investors begin to take interest. Recently, AppLovin (NASDAQ: APP) has captured the attention of many with its unusual options activity, hinting at potential market movements that traders shouldn't overlook. A Surge in...

Continue Reading
Empowering Youth Against Corruption: ICAC's Landmark Program

Updated Category News Views 135

Empowering Youth Against Corruption: ICAC's Landmark Program The Hong Kong International Academy Against Corruption, in collaboration with key international partners, has successfully launched the first-ever regional capacity building program focused on engaging youth in anti-corruption efforts. This initiative is crucial for fostering a culture of integrity among young...

Continue Reading
Innovaderm Research Strengthens Team with Rheumatology Expert

Updated Category News Views 78

Innovaderm Research Expands into Rheumatology Innovaderm Research, recognized for its expertise in dermatology, is thrilled to announce an important new addition to its team. Dr. Juan Gabriel Ovalles Bonilla, MD, PhD, an accomplished and board-certified rheumatologist, will be joining Innovaderm. His extensive experience brings added strength to the company’s efforts...

Continue Reading